Suppr超能文献

“每天服用这些药物,你会感到疲惫”:一项混合方法研究,旨在确定在塔索姆巴莱和塔索索罗蒂卓越中心感染艾滋病毒的青少年在坚持治疗和抑制艾滋病毒病毒载量方面的障碍和促进因素。

"Swallowing these drugs every day, you get tired": a mixed-methods study to identify Barriers and facilitators to retention and HIV Viral Load suppression among the Adolescents living with HIV in TASO Mbale and TASO Soroti centers of excellence.

作者信息

Oryokot Bonniface, Kazibwe Andrew, Oluka Abraham Ignatius, Kagimu David, Bakashaba Baker, Ssentongo Saadick, Mafabi Twaha, Odoi Charles, Kawuba Abubaker, Miya Yunus, Etukoit Bernard Michael, Mugisha Kenneth, Namusoke-Magongo Eleanor

机构信息

AIDS Information Centre.

The AIDS Support Organization.

出版信息

Res Sq. 2024 Jan 17:rs.3.rs-3863602. doi: 10.21203/rs.3.rs-3863602/v1.

Abstract

BACKGROUND

Adolescents aged 10-19, living with HIV (ALHIV) lag behind in attaining optimal viral load suppression (VLS) rates and retention in care, an important impediment to reaching epidemic control. This study aimed to identify barriers and facilitators to both VLS and retention among in the sub-population who seek care from TASO Mbale and TASO Soroti centers of excellence, to facilitate adaptation of the operation triple zero in the setting.

METHODS

We used a mixed methods approach, extracting secondary data on ALHIV who were active in care during April-June 2022 quarter to determine one year retention in care. Analysis was done in STATA Corp, 15.0. We used logistic regression to determine associated factors and adjusted odds ratio (aOR) to report level of predictability, using 95% confidence interval (CI) and P<0.05 for statistical significance. For qualitative component, purposive sampling of 59 respondents was done. Focused group discussions, key informant interviews, and in-depth interviews were used to collect data. Thematic content analysis was done using Atlas ti.

RESULTS

There were 533 ALHIV, with 12-month retention rate of 95.9% and VLS rate of 74.9%. Predictors for good VLS included good adherence [aOR:95%CI 0.066(0.0115, 0.38) P=0.02], being on first line treatment [aOR:95%CI 0.242 (0.0873,0.6724) P=0.006]. For retention, they include being a school going [aOR:95%CI 0.148(0.024,0.9218) P=0.041], multi month dispensing aOR:95%CI 32.6287(5.1446,206.9404) P<0.001, OVC enrolment aOR:95%CI 0.2625(0.083, 0.83) P=0.023]. Meanwhile key barriers included: individual ones such as internal stigma, lack of transport and treatment/drug fatigue; facility-level such as prolonged waiting time and lack of social activities; community level include stigma and discrimination, inadequate social support and food shortage. In terms of facilitators, individual level ones include good adherence and knowledge of one's HIV status; facility-level such as provision of adolescent friendly services and community-level such as social support and decent nutrition.

CONCLUSIONS

VLS rate was sub-optimal mainly due to poor adherence. HIV programs could utilize the barriers and facilitators identified to improve VLS. Conversely, retention rate at one year was good, likely due to provision of adolescent friendly health services. ALHIV and their caregivers need to be empowered to sustain retention and improve VLS.

CONTRIBUTIONS TO SCIENCE

By accentuating the barriers and facilitators to retention and VLS among the ALHIV, we ensure HIV programs continue to prioritize effective interventions and discard others as the epidemic evolves. To this, our findings strategically validate the effectiveness of provision of adolescent friendly services and client-centered care in attaining good retention rate.Secondly, being a mixed-methods study, complementarily adds value to the existing body of knowledge on barriers and facilitators while reminding programmers that VLS remains sub-optimal and more efforts are necessary.Finally, different stakeholders could use our findings to advocate for more resources to address some of the barriers such as food shortage, empowerment of ALHIV and caregivers and strengthening skilling programs for ALHIV, especially the out-of-school.

摘要

背景

10至19岁的青少年艾滋病毒感染者(ALHIV)在实现最佳病毒载量抑制(VLS)率和保持治疗依从性方面滞后,这是实现疫情控制的一个重要障碍。本研究旨在确定在向TASO姆巴莱和TASO索罗蒂卓越中心寻求治疗的亚人群中,VLS和保持治疗依从性的障碍及促进因素,以推动在该环境中实施“三零行动”。

方法

我们采用混合方法,提取2022年第二季度4月至6月期间接受治疗的ALHIV的二手数据,以确定一年的治疗保持率。分析在STATA Corp 15.0中进行。我们使用逻辑回归来确定相关因素,并使用调整后的优势比(aOR)来报告预测水平,使用95%置信区间(CI)和P<0.05表示统计学显著性。对于定性部分,对59名受访者进行了目的抽样。通过焦点小组讨论、关键信息提供者访谈和深入访谈来收集数据。使用Atlas ti进行主题内容分析。

结果

共有533名ALHIV,12个月的治疗保持率为95.9%,VLS率为74.9%。良好VLS的预测因素包括良好的依从性[aOR:95%CI 0.066(0.0115, 0.38) P=0.02],接受一线治疗[aOR:95%CI 0.242 (0.0873,0.6724) P=0.006]。对于治疗保持率,因素包括上学[aOR:95%CI 0.148(0.024,0.9218) P=0.041],多月配药aOR:95%CI 32.6287(5.1446,206.9404) P<0.001,孤儿和弱势儿童登记aOR:95%CI 0.2625(0.083, 0.83) P=0.023]。同时,关键障碍包括:个人层面的,如内心的耻辱感、缺乏交通和治疗/药物疲劳;机构层面的,如等待时间过长和缺乏社交活动;社区层面的包括耻辱和歧视、社会支持不足和食物短缺。在促进因素方面,个人层面的包括良好的依从性和对自身艾滋病毒状况的了解;机构层面的,如提供适合青少年的服务,社区层面的如社会支持和良好的营养。

结论

VLS率未达最佳主要是由于依从性差。艾滋病毒项目可利用所确定的障碍和促进因素来改善VLS。相反,一年的治疗保持率良好,可能是由于提供了适合青少年的健康服务。需要增强ALHIV及其护理人员的能力,以维持治疗保持率并改善VLS。

对科学的贡献

通过强调ALHIV中治疗保持率和VLS的障碍及促进因素,我们确保艾滋病毒项目在疫情演变过程中继续优先考虑有效的干预措施,并摒弃其他措施。为此,我们的研究结果从战略上验证了提供适合青少年的服务和以客户为中心的护理在实现良好治疗保持率方面的有效性。其次,作为一项混合方法研究,互补地为关于障碍和促进因素的现有知识体系增加了价值,同时提醒项目人员VLS仍未达最佳,需要更多努力。最后,不同的利益相关者可利用我们的研究结果来倡导提供更多资源,以解决一些障碍,如食物短缺、增强ALHIV及其护理人员的能力以及加强针对ALHIV尤其是失学青少年的技能培训项目。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验